Consistent with our bioinformatics analyses, CDCA3 protein levels strongly correlated with the sensitivity of NSCLC cell lines to cisplatin (r = −0.9; Fig. 1g) and to carboplatin (r = −0.85; Fig. 1h), whereby CDCA3high cell lines exhibited greatest cisplatin sensitivity. Here, CDCA3 is linked to non-small cell lung carcinoma.